Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Renal Failure|November 1, 1995
Effect of 1,25-dihydroxyvitamin D3 and diltiazem on tissue calcium in uremic ratO Inagaki, K Nakagawa, T Syono, et al.
Renal Failure|January 1, 1989
Effect of 1,25-dihydroxyvitamin D3 on intestinal glucose absorption in uremic ratsO Inagaki, T Syono, H Nagasaka, et al.
Electrophoresis|March 1, 1988
PI Mtoyoura: a new PI M subtype found by separator and hybrid isoelectric focusingI Yuasa, K Suenaga, K Umetsu, et al.
European Journal of Pharmacology|December 27, 1994
Pharmacological properties of YM-26365, a low molecular weight, orally active renin inhibitorM Shibasaki, K Shibasaki, M Ichihara, et al.
Nephron|January 1, 1986
Effect of 1,25-dihydroxyvitamin D3 on intestinal disaccharidases in uremic ratsO Inagaki, Y Fujita, S Inoue, et al.
Biological & Pharmaceutical Bulletin|March 8, 2000
Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension modelsT Tokioka, M Shibasaki, A Fujimori, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1990
Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agentM Asano, W Uchida, K Shibasaki, et al.
Biological & Pharmaceutical Bulletin|March 1, 1997
Cardiovascular effects of YM430, a 1,4-dihydropyridine derivative with beta-adrenoceptor blocking activity, in dogs and ratsK Shibasaki, W Uchida, K Takizawa, et al.
Chemical & Pharmaceutical Bulletin|July 11, 1998
Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivativesT Okazaki, T Watanabe, K Kikuchi, et al.
Intensive Care Medicine|March 1, 1995
Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assayT Saito, M Takanashi, E Gallagher, et al.
Pageof 7